The public-interest news organization ProPublica issued a new report that indicates manufacturers spent more in 2015 on physician payments for Xarelto than any other drug. These payments were not for research, but for things like consulting, meals, travel, promotional speaking, gifts, and royalties. In past studies, ProPublica … [Read more...]
Xarelto Manufacturer Leads Spending for Physicians’ Favor
Warfarin in Afib Patients Risk of Dementia
Warfarin Associated with Higher Rates of Dementia in Afib Patients. A study found that patients with atrial fibrillation, an abnormal heart rhythm that increases the risk for a blood clot, had a higher risk of dementia when taking the blood thinner warfarin compared to patients who do not have atrial fibrillation. Data was gathered … [Read more...]
Pretrial Proceedings Moving Forward in First Four Xarelto Bellwether Cases
In a recent court order, Judge Eldon Fallon, who oversees the Xarelto multidistrict litigation in the Eastern District of Louisiana, outlined the schedule for the first four trials. Judge Fallon has selected four cases to serve as the first bellwether cases. These cases will represent the thousands of other cases currently pending, … [Read more...]
Improper Use of Coumadin in Nursing Homes Leads to Deaths and Injuries
Coumadin, known generically as warfarin, is a popular decades-old blood thinner given to patients in order to reduce their risk of stroke and heart attack. It has benefits in patients who need it, but proper management needs to be implemented in order to keep patients safe. Patients taking Coumadin must avoid certain foods and … [Read more...]
Quality of Xarelto Clinical Trials Expected to be an Issue in 2017 Court Cases
When the first lawsuits involving the blood-thinning drug Xarelto go to trial in 2017, attorneys expect the quality of the clinical trials involved in the drug’s approval to be a major issue. Xarelto lawsuits have been filed in both federal courts and in state court in Pennsylvania. In both state and federal cases, plaintiffs who … [Read more...]
Pradaxa Linked to Brain Bleeds
Researchers report that they have found a possible link between the anticoagulant drug Pradaxa and intracerebral hemorrhage (brain bleeding). When a blood vessel wall or vein is damaged, the vessel can leak blood into tissues, causing a hematoma, a swelling of clotted blood within the tissues. The hematoma can be cause swelling and … [Read more...]
Xarelto Lawsuits Continue to Mount, Clinical Trials Under Scrutiny
According to court records, Bayer AG and Janssen Pharmaceuticals are facing close to 6,000 lawsuits alleging that the companies failed to warn about the risks associated with Xarelto, an anti-coagulant drug. Plaintiffs in the litigation allege that the blood thinner caused irreversible bleeding, because Xarelto lacks an antidote. … [Read more...]
